Waisman Center, University of Wisconsin-Madison, 1500 Highland Ave, Madison, WI, 53705, USA.
Department of Speech, Language, and Hearing Sciences, University of Arizona, 1131 2nd St , Tucson, AZ, 85721, USA.
Sci Rep. 2024 Sep 5;14(1):20707. doi: 10.1038/s41598-024-70810-y.
Fragile X-associated tremor/ataxia syndrome (FXTAS) is an age-related neurodegenerative disorder caused by a premutation of the FMR1 gene on the X chromosome. Despite the pervasive physical and cognitive effects of FXTAS, no studies have examined language in symptomatic males and females, limiting utility as an outcome measure in clinical trials of FXTAS. The goal of this work is to determine (a) the extent to which male and female FMR1 premutation carriers with FXTAS symptoms differ in their language use and (b) whether language production predicts FXTAS symptoms. Thirty-one individuals with the FMR1 premutation (21M, 10F), ages 58-85 years with some symptoms of FXTAS, were recruited from a larger cross-sectional study. Participants completed a five-minute monologic language sample. Language transcripts were assessed for rate of dysfluencies, lexical-semantics, syntax, and speech rate. Multivariable linear and ordinal regressions were used to predict FXTAS-associated symptoms, cognitive functioning, and executive functioning. Males and females did not differ in their language use. Language production predicted FXTAS symptom severity, cognitive functioning, and executive functioning. Language production difficulties may co-occur with FXTAS-associated symptoms and may be a viable outcome measure in future clinical trials, with future research needed.
脆性 X 相关震颤/共济失调综合征(FXTAS)是一种与年龄相关的神经退行性疾病,由 X 染色体上 FMR1 基因的前突变引起。尽管 FXTAS 具有普遍的身体和认知影响,但尚无研究检查有症状的男性和女性的语言,限制了其作为 FXTAS 临床试验的结果衡量标准的效用。这项工作的目的是确定(a)有 FXTAS 症状的男性和女性 FMR1 前突变携带者在语言使用方面存在差异的程度,以及(b)语言产生是否可以预测 FXTAS 症状。从一项更大的横断面研究中招募了 31 名具有 FMR1 前突变(21M,10F)的个体(年龄 58-85 岁,有一些 FXTAS 症状)。参与者完成了五分钟的独白语言样本。对语言转录本进行了不流畅、词汇语义、语法和语速的评估。使用多变量线性和有序回归来预测与 FXTAS 相关的症状、认知功能和执行功能。男性和女性在语言使用方面没有差异。语言产生预测了 FXTAS 症状的严重程度、认知功能和执行功能。语言产生困难可能与 FXTAS 相关症状同时发生,并且可能是未来临床试验中的一种可行的结果衡量标准,需要进一步研究。